Viacheslav Kopetskyi

ORCID: 0000-0003-3255-5599
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Intraperitoneal and Appendiceal Malignancies
  • Diversity and Career in Medicine
  • Endometrial and Cervical Cancer Treatments
  • Advances in Oncology and Radiotherapy
  • Global Cancer Incidence and Screening
  • Global Health and Surgery
  • Pancreatic and Hepatic Oncology Research
  • Gastric Cancer Management and Outcomes
  • Economic and Financial Impacts of Cancer
  • Gastrointestinal Tumor Research and Treatment
  • Gynecological conditions and treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Appendicitis Diagnosis and Management
  • Reproductive Biology and Fertility
  • Neuroendocrine Tumor Research Advances
  • Lymphoma Diagnosis and Treatment
  • Migration, Health and Trauma
  • Radiation Dose and Imaging
  • Palliative Care and End-of-Life Issues
  • International Science and Diplomacy
  • Health and Medical Research Impacts
  • Ultrasound in Clinical Applications
  • Pancreatitis Pathology and Treatment
  • Endometriosis Research and Treatment

Kyiv City Clinical Oncology Center
2024-2025

National Cancer Institute
2020-2024

Gynecologic Oncology Group
2019

Dzhemiliev, Ali MD; Kizub, Darya Welten, Vanessa M. MD, MPH; Shabat, Galyna Huivaniuk, Inesa Bielichenko, Svitlana Semeniv, Solomiia Zmijewski, Polina MA; Voitiv, Yaroslav PhD; Usenko, Olexander ScD; Beznosenko, Andriy Kopetskyi, Viacheslav Frolov, Serhii Melnitchouk, Nelya MSc Author Information

10.1097/sla.0000000000005873 article EN Annals of Surgery 2023-03-30

PURPOSE Cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) programs are often limited to centers in developed countries because of extensive requirements. We aimed analyze efficacy and challenges CRS/HIPEC lower-middle–income settings the Ukraine example. METHODS A multicenter descriptive study was conducted using data sets (2008-2022) from Kyiv, Lviv, Odesa centers. Patients with appendiceal neoplasm (AN); colorectal cancer (CRC); malignant peritoneal mesothelioma...

10.1200/go.23.00432 article EN cc-by-nc-nd JCO Global Oncology 2024-02-01

PURPOSE This study aims to identify the factors influencing colorectal cancer (CRC) screening practices, along with barriers and facilitators from perspective of primary care physicians (PCPs) in Ukraine. Considering health system challenges, including those posed by ongoing war, this research seeks inform improvements CRC outcomes Ukraine other low- middle-income countries (LMICs). METHODS A survey was designed distributed electronically Ukrainian PCPs, focusing on beliefs, barriers. The...

10.1200/go.24.00053 article EN cc-by-nc-nd JCO Global Oncology 2024-08-01

During military conflicts, the immediate response to a severely disrupted health care system often overlooks needs of patients with cancer who require continuous specialized care. The full-scale Russian invasion Ukraine in February 2022 was no exception, leaving many Ukrainian without access essential

10.1200/go-24-00363 article EN cc-by-nc-nd JCO Global Oncology 2024-10-01

PURPOSE Prompt diagnosis is a key step in starting effective cancer treatment. The earlier the disease detected, more opportunities for successful treatment and improved prognosis. We explored perceived factors affecting screening Ukraine, which faced multiple challenges following Russia's invasion. METHODS Online surveys assessing delays Ukraine were distributed to patients through cancer-focused social media April 2023. For who reported experiencing either or treatment, survey included...

10.1200/go-24-66000 article EN cc-by-nc-nd JCO Global Oncology 2024-07-01

PURPOSE Optimizing cancer care, including during the time of war, often begins with a needs assessment. We surveyed oncologists in Ukraine to evaluate existing gaps and describe strategies address them. METHODS In January 2024, medical surgical completed electronic surveys that were designed together at National Cancer Institute Ukraine. These included an open-ended question about how improve efficiency quality care one's practice. Surveys distributed through oncology-focused social media...

10.1200/go-24-55000 article EN cc-by-nc-nd JCO Global Oncology 2024-07-01

Abstract Background Gastric cancer remains one of the leading causes cancer-related morbidity and mortality. It requires combination chemotherapy surgery to achieve longest overall survival disease-free survival. However, regimens have a significant toxicity level that prevents patients from completing entire treatment protocol. Methods This is prospective randomized clinical trial aiming assess an intolerance related adverse effects in with resectable gastric receiving perioperative XELOX...

10.21203/rs.3.rs-1614408/v1 preprint EN cc-by Research Square (Research Square) 2022-05-18

<h3>Introduction/Background</h3> One of the key conditions for selecting candidates fertility sparing treatment (FST) is a tumour size not exceeding 2 cm in largest dimension. While there consensus on choice surgical stage IA, both radical (radical trachelectomy) and non-radical (simple trachelectomy or conisation) procedures are advocated IB1, often depending tumor (&gt;1 vs. 1–2 cm) presence LVSI. <h3>Methodology</h3> Patients with IB1 cervical cancer were recruited from international...

10.1136/ijgc-2022-esgo.372 article EN 2022-10-01

Рак яичника (РЯ) — наиболее агрессивная опухоль органов женской половой системы, характеризующаяся имплантационным ростом, поражением париетальной и висцеральной брюшины, а также брюшной полости забрюшинного пространства. Ежегодно РЯ в мире заболевает свыше 290 тысяч женщин, погибает 180 тысяч. III–IV стадии первично выявляется у 80 % пациенток. Оперативная тактика этой группы пациенток не может ограничиться классическими процедурами, такими как пангистерэктомия оментэктомия, включать...

10.22141/2663-3272.3.2.2020.215660 article RU Practical oncology 2020-12-04

e18769 Background: Because of Russia’s invasion Ukraine, many cancers are diagnosed at later stages, resulting in renewed emphasis on preventive medicine. To this end, we explored barriers and facilitators breast cancer screening Ukraine. Methods: A survey exploring factors that may influence was distributed through the Primary Care Physician Facebook group Chi-Squared Student’s t-tests tested association between discrete continuous variables, respectively. Linear logistic regression were...

10.1200/jco.2023.41.16_suppl.e18769 article EN Journal of Clinical Oncology 2023-06-01

Мета. Провести ретроспективний аналіз досвіду резекцій магістральних судин малого тазу. Висвітлити технічні аспекти втручань в залежності від типу резекції, варіанта реконструкції. Встановити причини ускладнень, намітити шляхи їх попередження та лікування.&#x0D; Матеріали і методи. За період з червня 2015 по квітень 2017 року проведено хірургічне лікування 31 хворого із злоякісними новоутвореннями тазу інвазією судин. Виконано резекцію 41 судини. Резекцію реконструкцію сегментів здухвинної...

10.26779/2522-1396.2018.02.32 article UK cc-by Klinicheskaia khirurgiia 2018-02-02

Мета. Покращення результатів лікування хворих з місцево-розповсюдженими та рецидивними солідними пухлинами черевної порожнини заочеревинного простору. &#x0D; Матеріали і методи. За період червня 2015 по січень 2018 р. в Національному інституті раку виконали комбіновані оперативні втручання нефректомією 28 хворим приводу первинних місцево-розповсюджених рецидивних солідних пухлин простору.&#x0D; Результати. У 5 із пацієнтів нефректомію ex vivo situ аутотрансплантацією нирки, у 4 - успішно....

10.26779/2522-1396.2018.11.61 article UK cc-by Klinicheskaia khirurgiia 2018-11-01

<h3>Introduction/Background</h3> The pillar of treatment advanced ovarian cancer is primary complete or at least optimal cytoreduction with further chemotherapy. Because complexity surgical debulking in upper abdomen there a tendency to perform non-optimal surgery neoadjuvant chemotherapy that can compromise long-term results. We hypothesized collaboration oncologist team treating patients GI tumors improve both number cytoreductions and completeness cytoreduction. <h3>Methodology</h3> have...

10.1136/ijgc-2019-esgo.939 article EN 2019-11-01

Ovarian cancer becomes the most aggressive disease among all pathology in women’s reproductive system. Surgery and chemotherapy are main options on way of ovarian treatment. Cytoreductive surgeries surgical treatment patients with advanced cancer. The goal this kind is resections macroscopic implants.The opportunity systematic lymph nodes dissection from renal vessels to obturator nerve reason scientific discussion. LION trial (Lymphadenectomy In Neoplasms) showed no significant difference...

10.18370/2309-4117.2020.55.90-93 article EN cc-by Reproductive Endocrinology 2020-11-30
Coming Soon ...